{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T09:46:35Z","timestamp":1782380795122,"version":"3.54.5"},"reference-count":41,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Approximately 30% of patients with tremor-dominant Parkinson\u2019s disease (PD) have rest tremor that persists despite optimal dopaminergic therapy. When deep brain stimulation and focused ultrasound are unavailable or declined, the therapeutic options narrow. Botulinum toxin (BoNT) offers a targeted, titratable, reversible approach, but whether a peripheral neuromuscular blocking agent makes sense for a centrally generated tremor is a legitimate question that deserves a direct answer. This narrative critical review appraises what is currently known across PD and non-PD tremor conditions, defines the technical requirements for safe and effective injection, and provides a practical framework for patient selection and clinical management. The PD-specific literature rests on a single positive double-blind randomized controlled trial of 30 patients; all remaining data are open-label or extrapolated from other tremor conditions, and this narrative synthesis combines heterogeneous conditions, outcome scales, and toxin protocols. A recurring technical observation is that, in the available trials, individualized, EMG-guided injection has been associated with substantially lower rates of hand weakness than fixed-dose injection (reported reductions from roughly 30\u201370% to below 15%) while maintaining tremor reduction, although the degree of benefit and weakness risk vary with the tremor syndrome, injected muscles, baseline impairment, dose, and guidance method. The careful patient selection this approach requires helps the individual clinician and patient achieve tremor relief, but it departs from the unselected real-world PD population and introduces selection bias that makes a large, statistically representative cohort difficult to assemble. In well-selected patients at centers with the appropriate expertise, BoNT may be a clinically useful option, but routine adoption is not yet supported.<\/jats:p>","DOI":"10.3390\/toxins18070280","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:14:12Z","timestamp":1782375252000},"page":"280","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Botulinum Toxin in Parkinson\u2019s Disease Tremor: A Critical Evaluation of the Evidence and Clinical Practice"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2138-1108","authenticated-orcid":false,"given":"Shivam Om","family":"Mittal","sequence":"first","affiliation":[{"name":"Movement Disorders Center, Cleveland Clinic Abu Dhabi, Abu Dhabi 112412, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8574-3297","authenticated-orcid":false,"given":"Wolfgang H.","family":"Jost","sequence":"additional","affiliation":[{"name":"Parkinson-Klinik Ortenau, 77709 Wolfach, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/archneur.1986.00520020020009","article-title":"Pharmacologic treatment of Parkinsonian tremor","volume":"43","author":"Koller","year":"1986","journal-title":"Arch. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.27121","article-title":"Consensus statement on the classification of tremors from the task force on tremor of the International Parkinson and Movement Disorder Society","volume":"33","author":"Bhatia","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1523\/JNEUROSCI.3634-15.2016","article-title":"The cerebral network of Parkinson\u2019s tremor: An effective connectivity fMRI study","volume":"36","author":"Dirkx","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/brain\/aws023","article-title":"Cerebral causes and consequences of parkinsonian resting tremor: A tale of two circuits?","volume":"135","author":"Helmich","year":"2012","journal-title":"Brain"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clinph.2011.09.024","article-title":"The oscillating central network of essential tremor","volume":"123","author":"Raethjen","year":"2012","journal-title":"Clin. Neurophysiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8","article-title":"Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection","volume":"19","author":"Rosales","year":"1996","journal-title":"Muscle Nerve"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e1413","DOI":"10.1212\/WNL.0000000000012662","article-title":"Changes in Cortical Excitability and Parkinson Tremor After Botulinum Toxin Therapy","volume":"97","author":"Samotus","year":"2021","journal-title":"Neurology"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Das, A., and Jog, M. (2025). Effect of botulinum toxin on sensorimotor integration in movement disorders: A scoping review. Toxins, 17.","DOI":"10.3390\/toxins17080416"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/mds.870090604","article-title":"Botulinum toxin A injections for the treatment of hand tremors","volume":"9","author":"Trosch","year":"1994","journal-title":"Mov. Disord."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archneur.1996.00550070055012","article-title":"Approach to the treatment of limb disorders with botulinum toxin A: Experience with 187 patients","volume":"53","author":"Pullman","year":"1996","journal-title":"Arch. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.mayocp.2017.06.010","article-title":"Botulinum toxin in Parkinson disease tremor: A randomized, double-blind, placebo-controlled study with a customized injection approach","volume":"92","author":"Mittal","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Niemann, N., and Jankovic, J. (2018). Botulinum toxin for the treatment of hand tremor. Toxins, 10.","DOI":"10.3390\/toxins10070299"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/mdc3.70079","article-title":"Botulinum toxin for proximal upper limb tremor: A randomized double-blind placebo-controlled crossover trial","volume":"12","author":"Nagaratnam","year":"2025","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Samotus, O., Lee, J., and Jog, M. (2017). Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0178670"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1756286420954083","DOI":"10.1177\/1756286420954083","article-title":"Standardized algorithm for muscle selection and dosing of botulinum toxin for Parkinson tremor using kinematic analysis","volume":"13","author":"Samotus","year":"2020","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bellows, S., and Jankovic, J. (2025). Botulinum toxin for the treatment of tremors. Toxins, 17.","DOI":"10.3390\/toxins17080401"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.870110306","article-title":"A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor","volume":"11","author":"Jankovic","year":"1996","journal-title":"Mov. Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.56.11.1523","article-title":"A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor","volume":"56","author":"Brin","year":"2001","journal-title":"Neurology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.parkreldis.2018.06.019","article-title":"Botulinum toxin in essential hand tremor: A randomized double-blind placebo-controlled study with customized injection approach","volume":"56","author":"Mittal","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Jog, M., Lee, J., Scheschonka, A., Chen, R., Ismail, F., Boulias, C., Hobson, D., King, D., Althaus, M., and Simon, O. (2020). Tolerability and efficacy of customized IncobotulinumtoxinA injections for essential tremor: A randomized, double-blind, placebo-controlled study. Toxins, 12.","DOI":"10.3390\/toxins12120807"},{"key":"ref_22","unstructured":"Patel, A., Patterson, K., Khosla, D., Patterson, K., Khosla, D., Alibhai, N., and James, L. (2025, January 5\u20139). Results from the ELATE trial: A Phase 2 multicenter, randomized, double-blind, placebo-controlled study of onabotulinumtoxinA for the treatment of upper limb essential tremor. Presented at the International Congress of Parkinson\u2019s Disease and Movement Disorders (MDS), Honolulu, HI, USA."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/mdc3.70307","article-title":"Botulinum toxin efficacy in upper limb tremor: A systematic review and meta-analysis","volume":"13","author":"Visser","year":"2025","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1056\/NEJMoa2304192","article-title":"Trial of botulinum toxin for isolated or essential head tremor","volume":"389","author":"Marques","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/jamaneurol.2020.4766","article-title":"Assessment of botulinum neurotoxin injection for dystonic hand tremor: A randomized clinical trial","volume":"78","author":"Rajan","year":"2021","journal-title":"JAMA Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1212\/WNL.0b013e31825dcdd9","article-title":"A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor","volume":"79","author":"Sung","year":"2012","journal-title":"Neurology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1177\/1352458519837706","article-title":"OnabotulinumtoxinA treatment for MS-tremor modifies fMRI tremor response in central sensory-motor integration areas","volume":"26","author":"Boonstra","year":"2020","journal-title":"Mult. Scler."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/WNL.45.4.822","article-title":"Botulinum toxin treatment of essential head tremor","volume":"45","author":"Pahwa","year":"1995","journal-title":"Neurology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/01.WNF.0000236765.00785.9C","article-title":"Treatment of primary writing tremor with botulinum toxin type A: Report of a case series","volume":"29","author":"Papapetropoulos","year":"2006","journal-title":"Clin. Neuropharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2054-7072-1-5","article-title":"Epidemiology and treatment of 23 musicians with task-specific tremor","volume":"1","author":"Lee","year":"2014","journal-title":"J. Clin. Mov. Disord."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jocn.2012.12.025","article-title":"Safety and efficacy of botulinum toxin in primary orthostatic tremor","volume":"20","author":"Bertram","year":"2013","journal-title":"J. Clin. Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s10072-015-2285-z","article-title":"Botulinum toxin type A for Holmes tremor secondary to thalamic hemorrhage","volume":"36","author":"Latino","year":"2015","journal-title":"Neurol. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1212\/WNL.41.10.1677","article-title":"Ear click in palatal tremor: Its origin and treatment with botulinum toxin","volume":"41","author":"Deuschl","year":"1991","journal-title":"Neurology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/mds.870130516","article-title":"Treatment of hereditary trembling chin with botulinum toxin","volume":"13","author":"Bakar","year":"1998","journal-title":"Mov. Disord."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/mds.21019","article-title":"Botulinum toxin A may be efficacious for jaw tremor in Parkinson\u2019s disease","volume":"21","author":"Schneider","year":"2006","journal-title":"Mov. Disord."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"107522","DOI":"10.1016\/j.bspc.2025.107522","article-title":"A generalized coherence framework for quantifying input contributions in multi-input systems with correlated or uncorrelated inputs","volume":"104","author":"Howes","year":"2025","journal-title":"Biomed. Signal Process. Control"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.5535\/arm.240065","article-title":"Ultrasonography for assessment and intervention with botulinum toxin injection for tremors","volume":"48","author":"Park","year":"2024","journal-title":"Ann. Rehabil. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5334\/tohm.582","article-title":"Novel botulinum toxin injection protocols for Parkinson tremor and essential tremor: The EMG-guided and sensor-based kinematics procedures","volume":"10","author":"Mittal","year":"2020","journal-title":"Tremor Other Hyperkinet. Mov."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"120203","DOI":"10.1016\/j.jns.2022.120203","article-title":"Botulinum toxin for the treatment of tremor","volume":"435","author":"Mittal","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.parkreldis.2019.01.023","article-title":"Botulinum toxin for the treatment of tremor","volume":"63","author":"Mittal","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_41","unstructured":"Gronseth, G.S., Cox, J., Gloss, D., Merillat, S., Dittman, J., Armstrong, M.J., Getchius, T.S.D., and on behalf of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology (2017). Clinical Practice Guideline Process Manual, American Academy of Neurology. [2017th ed.]."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/7\/280\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:54:59Z","timestamp":1782377699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/7\/280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["toxins18070280"],"URL":"https:\/\/doi.org\/10.3390\/toxins18070280","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]}}}